US Stem Cell Inc (USRM)

[Archery Class]

The longer the silence, the less confident your typical holder becomes.

However at this point it also isn't worth the risk to jump ship. That's a typical action that usually leads to regret.

Surprised that this tipped .17 and floated back down. That would generally mean RMAT places above .20 with future positive actions from the FDA driving up in stair stepping fashion.